NPPB and neoplasm: Greater NT-proBNP concentration was associated with shorter 5-year survival of brain tumor patients independently of age, gender, histories of cardiovascular disease, tumor grade, and adjuvant therapies, indicating that NT-proBNP can be a valuable prognostic biomarker above and beyond established clinical prognostic indicators.